Evidence map›Paper›PMID 42204035›Full record

ArticleInternational journal of clinical oncology2026

Quantitative evaluation of healthcare information provided to patients with thoracic malignancies: patient satisfaction survey of the Japan Lung Cancer Society.

Takayuki Takahama, Hidefumi Shimizu, Kenichi Yoshimura, Hidehito Horinouchi, Hiroyasu Kaneda, Kiyotaka Watanabe, Hiromi Aono, Keiko Tanaka, Seiki Hasegawa, Tomohiro Osawa and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Takayuki TakahamaDepartment of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
Hidefumi ShimizuDepartment of Respiratory Medicine, JCHO Tokyo Shinjuku Medical Center, Shinjuku, Japan.
Kenichi YoshimuraDepartment of Biostatistics and Health Data Science, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.
Hidehito HorinouchiDepartment of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Hiroyasu KanedaDepartment of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kiyotaka WatanabeDepartment of Medicine, School of Medicine, Teikyo University, Tokyo, Japan.
Hiromi AonoDepartment of Respiratory Medicine, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Keiko TanakaFormerly of Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Seiki HasegawaDepartment of Thoracic Surgery, Takarazuka City Hospital, Takarazuka, Japan.
Tomohiro OsawaDepartment of Pharmacy, Gifu Municipal Hospital, Gifu, Japan.
Hidetoshi HayashiDepartment of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
Takeshi YoshidaDepartment of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
Yasuhisa OhdeDivision of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Tomoki KimuraDepartment of Radiation Oncology, Kochi Medical School, Kochi University, Kochi, Japan.
Mitsutoshi AkihoDepartment of Rehabilitation Sciences, University of Tokyo Health Sciences, Tokyo, Japan.
Hatoe SakamotoSupportive Care Center, National Cancer Center Hospital East, Kashiwanoha, Japan.
Mayumi ItoThe Japan Lung Cancer Society, Tokyo, Japan.
Kazuo HasegawaNPO Lung Cancer Patient Network ONE STEP, Yokohama, Japan.
Koji OnishiMie Lung Cancer Patients Association, Tokyo, Japan.
Jiichiro SasakiDivision of Clinical Oncology, Department of Comprehensive Medicine, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
Satoshi OizumiDepartment of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan.
Tetsuya MitsudomiDepartment of Thoracic Surgery, Izumi City General Hospital, and Faculty of Medicine, Kindai University, Osaka, Japan.
Akihiko GemmaDepartment of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.
Toshiyuki SawaCentral Japan International Medical Center, Medical Oncology, Gifu, Japan. sawatoshiyuki@yahoo.co.jp.ORCID http://orcid.org/0000-0003-0705-3781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare professionals are increasingly providing medical information to patients. However, few objective evaluations of the information's usefulness exist. This study aimed to evaluate patient satisfaction with medical information sources, including the JLCS Guidebook and patient advocacy groups, using the European Organization for Research and Treatment of Cancer's (EORTC) Quality of Life 25-item information module (QLQ-INFO25).

methodsPatients with thoracic malignancies were enrolled in the trial in response to calls from patient support groups and the Japanese Lung Cancer Society. Patient satisfaction was based on information obtained from the 2019 Japanese Lung Cancer Society's patient guidebook and a web-based survey of patients with lung cancer. Satisfaction with the information was analyzed using EORTC QLQ-INFO25 scores and stratified by guidebook use (users vs. non-users).

resultsOf 332 participants (110 male, 222 female), 283 (85.2%) completed the questionnaire, among which 82 (29.0%) read the guidebook. Participants found the research through online sources or by responding to an invitation from their primary physician or patient support group. Seventy-one users (91%) were satisfied with the guidebook content, as indicated by their individual QLQ-INFO25 scale scores. No statistically significant differences were observed between guidebook users and non-users; however, a trend toward higher satisfaction was noted among participants who used both the guidebook and advocacy groups.

conclusionsOur findings suggest that guidebooks and advocacy groups may contribute to improved patient satisfaction; however, further controlled studies are warranted. Our results provide an objective basis for discussing information provision for patients with lung cancer. Strategies should be developed to communicate information reflecting patients' diverse backgrounds.

Indexed as

Lung NeoplasmsPatient Education as TopicPatient SatisfactionThoracic NeoplasmsAdultAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedQuality of LifeSurveys and QuestionnairesEORTC QLQ-INFO25Information for the patientsPatient advocacyPatient guidebookPatient information guideQuestionnaire

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.